American Vanguard (AVD) to Release Earnings on Monday

American Vanguard (NYSE:AVD) is set to release its earnings data after the market closes on Monday, November 11th. Analysts expect American Vanguard to post earnings of ($0.10) per share for the quarter. Persons that are interested in participating in the company’s earnings conference call can do so using this link.

American Vanguard (NYSE:AVD) last posted its quarterly earnings results on Thursday, August 8th. The basic materials company reported ($0.09) earnings per share (EPS) for the quarter, missing the consensus estimate of ($0.01) by ($0.08). American Vanguard had a negative net margin of 0.60% and a positive return on equity of 1.85%. The business had revenue of $128.21 million during the quarter, compared to analyst estimates of $134.20 million. On average, analysts expect American Vanguard to post $0 EPS for the current fiscal year and $0 EPS for the next fiscal year.

American Vanguard Stock Performance

AVD opened at $5.77 on Friday. American Vanguard has a 1-year low of $4.95 and a 1-year high of $14.28. The company has a market cap of $166.41 million, a price-to-earnings ratio of -48.08 and a beta of 0.88. The company’s fifty day moving average price is $5.52 and its two-hundred day moving average price is $7.55. The company has a current ratio of 2.22, a quick ratio of 1.08 and a debt-to-equity ratio of 0.60.

Insider Buying and Selling

In other news, Director Keith M. Rosenbloom acquired 25,000 shares of the firm’s stock in a transaction on Tuesday, September 3rd. The stock was purchased at an average price of $5.94 per share, for a total transaction of $148,500.00. Following the purchase, the director now owns 1,193,682 shares in the company, valued at approximately $7,090,471.08. This represents a 0.00 % increase in their position. The purchase was disclosed in a document filed with the SEC, which can be accessed through the SEC website. In related news, Director Keith M. Rosenbloom purchased 33,555 shares of American Vanguard stock in a transaction that occurred on Wednesday, August 28th. The stock was bought at an average price of $5.66 per share, for a total transaction of $189,921.30. Following the completion of the transaction, the director now owns 1,047,410 shares in the company, valued at $5,928,340.60. This represents a 0.00 % increase in their ownership of the stock. The acquisition was disclosed in a filing with the SEC, which is accessible through this hyperlink. Also, Director Keith M. Rosenbloom acquired 25,000 shares of the firm’s stock in a transaction that occurred on Tuesday, September 3rd. The shares were bought at an average price of $5.94 per share, with a total value of $148,500.00. Following the acquisition, the director now directly owns 1,193,682 shares of the company’s stock, valued at $7,090,471.08. The trade was a 0.00 % increase in their position. The disclosure for this purchase can be found here. Over the last ninety days, insiders have bought 163,047 shares of company stock worth $938,205. 10.10% of the stock is owned by insiders.

Wall Street Analysts Forecast Growth

A number of equities research analysts recently weighed in on the stock. StockNews.com upgraded shares of American Vanguard from a “sell” rating to a “hold” rating in a report on Wednesday, September 25th. Lake Street Capital assumed coverage on American Vanguard in a research note on Monday, July 22nd. They issued a “buy” rating and a $14.00 price objective for the company. One research analyst has rated the stock with a hold rating and four have assigned a buy rating to the company. According to MarketBeat, the company has an average rating of “Moderate Buy” and an average price target of $16.67.

American Vanguard Company Profile

American Vanguard Corporation, through its subsidiaries, develops, manufactures, and markets specialty chemicals for agricultural, commercial, and consumer uses in the United States and internationally. It manufactures and formulates chemicals, including insecticides, fungicides, herbicides, soil health, plant nutrition, molluscicides, growth regulators, soil fumigants, and biorationals in liquid, powder, and granular forms for crops, turf and ornamental plants, and human and animal health protection.